[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354405-105":59,"doc-detail-354405-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","intratumoral-microbiome-a-key-regulator-and-novel-therapeutic-target-for-chemoresistance-in-pancreatic-cancer-review","Intratumoral microbiome - a key regulator and novel therapeutic target for chemoresistance in pancreatic cancer - Review","","Pancreatic cancer remains highly lethal, and chemotherapy resistance is a major barrier to improving outcomes. This review explains how the intratumoral microbiome contributes to tumor development, progression, and treatment response, focusing on community composition, regulatory roles, and mechanisms behind chemoresistance. It highlights microbiota-driven immune microenvironment remodeling, DNA damage, oncogenic signaling, extracellular matrix changes, immunosuppression, and metabolic inactivation of chemotherapeutic agents.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/intratumoral-microbiome-a-key-regulator-and-novel-therapeutic-target-for-chemoresistance-in-pancreatic-cancer-review/354405/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/intratumoral-microbiome-a-key-regulator-and-novel-therapeutic-target-for-chemoresistance-in-pancreatic-cancer-review/354405.png","ImageObject",300,407,{"name":92,"@type":93},"Mary Man","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"Which microbial groups are mainly reported in pancreatic cancer intratumoral microbiome?","Question",{"text":112,"@type":113},"The review states that the intratumoral microbiome of pancreatic cancer is mainly composed of Proteobacteria and Firmicutes, with composition correlated with patient survival.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},354405,1790933538,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":131,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":132,"faqs":133,"seo_title":134,"seo_description":67,"update_tm":135,"read_time":136,"preview_page_count":19,"preview_urls":137},7421720224475,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","TYPE Review  \nPUBLISHED 19 June 2026  \nDOI 10.3389/fcimb.2026.1860523  \nOPEN ACCESS  \nEDITED BY  \nAmanda Carroll-Portillo,  \nUniversity of New Mexico, United States  \nREVIEWED BY  \nWioletta Adamus-Białek, Jan Kochanowski University, Poland Dhanisha Sulekha Suresh, The University of Iowa, United States  \n*CORRESPONDENCE  \nJiao Wu  \n[1107910010@qq.com](1107910010@qq.com)  \nRECEIVED 20 April 2026  \nREVISED 29 May 2026  \nACCEPTED 09 June 2026  \nPUBLISHED 19 June 2026  \nCITATION  \nWang Y and Wu J (2026) Intratumoral microbiome: a key regulator and novel therapeutic target for chemoresistance in pancreatic cancer. Front. Cell. Infect. Microbiol. 16:1860523 .  \ndoi: 10.3389/fcimb.2026.1860523  \nCOPYRIGHT  \n© 2026 Wang and Wu. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nIntratumoral microbiome: a key regulator and novel therapeutic target for chemoresistance in pancreatic cancer  \nYunpeng Wang 1 and Jiao Wu 2*  \n1 Department of Cardiology, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China, 2 Department of Gastroenterology, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China  \nPancreatic cancer is a highly lethal gastrointestinal malignancy with chemotherapy resistance as a major obstacle to improving prognosis. Emerging evidence indicates that the intratumoral microbiome is closely implicated in the development, progression, and therapeutic response of pancreatic cancer . The intratumoral microbiome of pancreatic cancer is mainly composed of Proteobacteria and Firmicutes, and its composition is signiﬁcantly correlated with patient survival. Intratumoral microbes drive tumor progression by remodeling the immune microenvironment, inducing DNA damage, and activating oncogenic signaling pathways. Meanwhile, they exacerbate chemotherapy resistance via multiple mechanisms, including remodeling the extracellular matrix, establishing an immunosuppressive microenvironment, and metabolically inactivating chemotherapeutic agents. This review systematically summarizes the community composition of the intratumoral microbiome in pancreatic cancer, its regulatory effects, and underlying mechanisms on chemotherapy resistance, as well as the latest advances in targeted therapeutic strategies.  \nKEYWORDS  \nchemotherapy resistance, intratumoral microbiome, pancreatic cancer, therapeutic target, tumor microenvironment  \nIntroduction  \nData from the American Cancer Society, derived from 2021 incidence data of the Central Cancer Registry and 2022 mortality data from the National Center for Health Statistics, projected that pancreatic cancer will become the third leading cause of cancerrelated mortality in the United States by 2025 (Siegel et al., 2025) and rise to the second leading cause by 2030 (Rahib et al., 2021) . The incidence-to-mortality ratio of pancreatic cancer in the United States is 1.3:1. In China, although pancreatic cancer ranks sixth among all cancer-related deaths, its incidence-to-mortality ratio is 1.12:1 (Han et al., 2024) . Notably, pancreatic cancer has the highest incidence-to-mortality ratio across all malignancies in both countries. A major obstacle to the treatment of pancreatic cancer is its insidious onset. Due to the absence of speciﬁc early symptoms and its inherent invasive  \nFrontiers in Cellular and Infection Microbiology 01 [frontiersin.org](frontiersin.org)  \nnature, most patients are diagnosed at an advanced stage with established distant metastasis (Stoop et al., 2025) . Accordingly","cbCaie5VpS9BU2fr","https://ap.wps.com/l/cbCaie5VpS9BU2fr","pdf",1109269,"English","# Introduction\n## Epidemiology and clinical challenge of pancreatic cancer\n## Treatment strategy and chemotherapy regimens\n# Intratumoral microbiome composition and prognostic relevance\n# Mechanisms linking intratumoral microbes to tumor progression\n# Intratumoral microbiome mechanisms of chemotherapy resistance\n# Targeted therapeutic advances based on the intratumoral microbiome","[{\"question\":\"Which microbial groups are mainly reported in pancreatic cancer intratumoral microbiome?\",\"answer\":\"The review states that the intratumoral microbiome of pancreatic cancer is mainly composed of Proteobacteria and Firmicutes, with composition correlated with patient survival.\"}]","Intratumoral microbiome - a key regulator and novel therapeutic target for chemoresistance in pancreatic cancer - Review | PDF",1790110481,25,[138,142,146,150],{"page_no":8,"url":139,"width":140,"height":141},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7722836237b12d6c0884a1354a53ad7f.webp",983,1389,{"page_no":14,"url":143,"width":144,"height":145},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2a8ef9b1f9a5b44236314d9679d6439.webp",982,1388,{"page_no":81,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99ed10c4bb989930113f6ecdb7c42edc.webp",981,1386,{"page_no":19,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a73e3b8e2a769aa44cba96d14b90fac4.webp",980,1385]